Kevin Hanley
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Kevin Hanley
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kevin Hanley
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Axtria, Inc.
Axtria, Inc. Packaged SoftwareTechnology Services Axtria, Inc. provides customized analytics software and client consulting services. The firm?s solutions include decision science, commercial operations cloud and cloud information management. The company was founded by Jaswinder S. Chadha and Navdeep Chadha in 2010 and is headquartered in Berkeley Heights, NJ. | Packaged Software | Director/Board Member Founder Director/Board Member | |
Augmenix, Inc.
Augmenix, Inc. Medical SpecialtiesHealth Technology Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA. | Medical Specialties | Chief Executive Officer Chairman | |
Rejoni, Inc.
Rejoni, Inc. BiotechnologyHealth Technology Rejoni, Inc. engages in the provision of biotechnology services. It focuses on developing products that improve the outcomes of minimally invasive and other gynecological surgical procedures. The company was founded in June 2020 and is headquartered in Bedford, MA. | Biotechnology | President Chief Executive Officer | |
marketRx LLC
marketRx LLC Miscellaneous Commercial ServicesCommercial Services marketRx LLC offers analytics, market research and software services to life sciences companies. It delivers sales management and operations, brand marketing and product management, and market research services. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Indian Institute of Technology New Delhi | College/University | Undergraduate Degree Undergraduate Degree | |
AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Panjab Digital Library | Director/Board Member | ||
University of Texas at El Paso | College/University | Graduate Degree | |
New Jersey Technology Council
New Jersey Technology Council Miscellaneous Commercial ServicesCommercial Services New Jersey Technology Council provides business development, education and advocacy services. It serves communications, e-business, multimedia, consumer technologies, manufacturing, engineering and energy sectors. The company was founded in 1996 and is headquartered in New Brunswick, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
South Asian Pharmaceutical Council | Director/Board Member | ||
The Indus Entrepreneurs
The Indus Entrepreneurs Miscellaneous Commercial ServicesCommercial Services The Indus Entrepreneurs is a non-profit organization. It provides mentoring, networking, education and funding to entrepreneurs. The company was founded in 1992 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Director/Board Member | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | General Counsel | |
Instylla, Inc.
Instylla, Inc. Miscellaneous Commercial ServicesCommercial Services Instylla, Inc. operates as a biotechnology company. Its focus is to leverage hydrogel technology to create differentiated liquid embolics for interventional radiology with a specific initial focus on interventional oncology and peripheral hemostasis. The company was founded by Amarpreet Sawhney and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Ostial Corp.
Ostial Corp. Medical/Nursing ServicesHealth Services Ostial Corp. develops catheter-based delivery system combined with a bare metal stent. The firm allows physicians to perform aorto-ostial interventions with precision and predictability. The company was founded by Fred Khosravi in 2008 and is headquartered in Campbell, CA. | Medical/Nursing Services | Director/Board Member | |
TiE Boston
TiE Boston Investment ManagersFinance TiE Boston is a private equity firm founded by by Desh Deshpande in 1997. The firm is headquartered in Boston, MA. | Investment Managers | Corporate Officer/Principal | |
Incept LLC
Incept LLC Miscellaneous Commercial ServicesCommercial Services Incept LLC operates as a biotechnical research company. It focuses in the life-sciences space, and occasional involvement in select information technology opportunities. The company was founded in 1998 by Farhad Khosravi and Amarpreet S. Sawhney and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Founder | |
A.T. Kearney, Inc.
A.T. Kearney, Inc. Miscellaneous Commercial ServicesCommercial Services A.T. Kearney, Inc. engages in the provision of management consulting services. Its services include strategic, operational and technology consulting executive search services. The company was founded by Andrew Thomas Kearney in 1926 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
Tufts University | College/University | Undergraduate Degree | |
Cellemedy Co., Ltd.
Cellemedy Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Cellemedy Co., Ltd. develops next-generation cancer treatments to improve the health of people suffering from cancer. The company is based in Seongnam-si, South Korea. The South Korean company was founded in 2016. The CEO is Ha-Chul Kim. | Miscellaneous Commercial Services | President | |
Tulavi Therapeutics, Inc.
Tulavi Therapeutics, Inc. BiotechnologyHealth Technology Tulavi Therapeutics, Inc. develops therapeutics to treat neurally mediated diseases. It helps to treat aberrant neural reflex arcs in peripheral and visceral diseases. The company was founded was founded by Corinne Bright, Fred Khosravi and Henry Chen and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member | |
Cybernetix Ventures Managemnet Co LLC
Cybernetix Ventures Managemnet Co LLC Investment ManagersFinance Cybernetix Ventures Management Co.LLC (Cybernetix Ventures ) is a venture capital firm founded in 2018 by Mark Martin and Fady Saad. The firm headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Arizona State University | College/University | Undergraduate Degree | |
Novelgen Co. Ltd(South Korea) | Director/Board Member | ||
Novalgen Ltd.
Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Celltrion Healthcare Japan KK | President | ||
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Seoul National University | College/University | Doctorate Degree | |
CELLTRION HEALTHCARE CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
Northcentral University | College/University | Masters Business Admin | |
University of Baroda | College/University | Undergraduate Degree | |
The California State University | College/University | Undergraduate Degree | |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
Sofregen Medical, Inc.
Sofregen Medical, Inc. BiotechnologyHealth Technology Sofregen Medical, Inc. develops innovative silk-based solutions for soft tissue defects. Its products: SERI silk derived surgical scaffold is knitted scaffold made from ultra-pure, sterile, silk-derived bioprotein that facilitates neovascularization and native tissue regeneration over time and Sofregen technology a silk derived material for medical application. The company was founded by Anh Hoang and Howard J. Weisman on May 19, 2014 and is headquartered in Cambridge, MA. | Biotechnology | President | |
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Medical Specialties | Founder | |
The University of Texas at Austin | College/University | Doctorate Degree | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel | |
TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BTG | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigte Staaten | 39 |
Südkorea | 5 |
Indien | 4 |
Vereinigtes Königreich | 4 |
Bermuda | 2 |
Sektoral
Health Technology | 24 |
Consumer Services | 11 |
Commercial Services | 9 |
Finance | 3 |
Technology Services | 2 |
Operativ
Director/Board Member | 41 |
Corporate Officer/Principal | 18 |
President | 14 |
Founder | 11 |
Chief Executive Officer | 11 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Kevin Hanley
- Unternehmensverbindungen